September 18, 2018:
With the Health Canada approval of the chimeric antigen receptor T cell (CAR-T) therapy, Kymriah (tisagenlecleucel/CTL019), Ac2orn encourages the provincial health funding agencies to finalize their funding agreements for Kymriah to add it to the provincial formularies. Press Release (PDF)
September 6, 2018:
Ac2orn congratulates Novartis for the approval of Kymriah by Health Canada, the first Canadian approval of a chimeric antigen receptor T cell (CAR T cell) therapy, for relapsed and refractory acute lymphoblastic leukemia (ALL). Press Release (PDF)
June 6, 2018:
30 leading pediatric oncologists and researchers and 31 cancer organizations from across North America have signed the proposal.
May 17, 2018:
Over 23 leading pediatric oncologists and researchers, and 27 cancer organizations from across North America, are shedding light on the inequitable access to promising early phase clinical trials for Canadian children, adolescents and young adults (CAYA) with cancer and offering solutions to ensure no child gets left behind.
Authored by Advocacy for Canadian Childhood Oncology Research Network (Ac2orn), with assistance from the C17 Council and Helena’s Hope: Pathways to More Kids Surviving Cancer, the proposal “Improving Outcomes for Canadian Children, Adolescents, and Young Adults with Cancer: A proposal for a working relationship with Health Canada”, provides actionable feedback from researchers and clinicians across the country.
September 30, 2015:
Terry Fox is the first person to be honoured with the Ac2orn Order of the Oak award recognizing excellence in childhood, adolescent and young adult cancer research and advocacy in Canada.
Advocacy for Canadian Childhood Oncology Research Network, Ac2orn, announced today that Terry Fox will receive the first Order of the Oak award recognizing excellence in childhood, adolescent and young adult cancer research and advocacy in Canada. The Order of the Oak is an award that will be given out yearly during the month of September in recognition of childhood cancer awareness month. Press Release (PDF).
For media requests, please use our Contact page.